| Dr Esad Ulker, MD | |
|
750 Brunswick Ave, Trenton, NJ 08638-4143 | |
| (609) 394-6031 | |
| Not Available |
| Full Name | Dr Esad Ulker |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 750 Brunswick Ave, Trenton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750918066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD481192 (Pennsylvania) | Primary |
| Entity Name | Hospitalist Medicine Physicians Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639464308 PECOS PAC ID: 9234309840 Enrollment ID: O20110908001888 |
News Archive
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.
GlaxoSmithKline and Valeant Pharmaceuticals International announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to 30 November 2010.
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).
Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Esad Ulker, MD 559 W Germantown Pike, East Norriton, PA 19403-4250 Ph: (484) 622-4245 | Dr Esad Ulker, MD 750 Brunswick Ave, Trenton, NJ 08638-4143 Ph: (609) 394-6031 |
News Archive
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.
GlaxoSmithKline and Valeant Pharmaceuticals International announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to 30 November 2010.
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).
Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.
› Verified 6 days ago
Dr. Julie M. Pantelick, D.O. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 601 Hamilton Ave, Suite #b158, Trenton, NJ 08629 Phone: 609-599-5139 Fax: 609-599-5047 | |
Dr. Sheema Jalil, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 735 Hamilton Ave, Hamilton Hospitalists, Trenton, NJ 08629 Phone: 609-581-6666 Fax: 609-585-0309 | |
John Harry Lagonikos, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Hamilton Ave, Trenton, NJ 08629 Phone: 609-599-5061 | |
Rajmayur P Brahmbhatt, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hamilton Health Pl, Trenton, NJ 08690 Phone: 609-584-6593 | |
Dr. Hardawan Ahmed Hassan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6031 | |
Djamshed Samiev, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6031 |